# Celecoxib Efficacy And Safety Versus Diclofenac In Acute Pain Due To Cervical Sprain Related To A Traffic Accident

> **NCT00894790** · PHASE4 · TERMINATED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 8 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Celecoxib
- **DRUG:** oral Diclofenac

## Key facts

- **NCT ID:** NCT00894790
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-11
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2021-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00894790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00894790, "Celecoxib Efficacy And Safety Versus Diclofenac In Acute Pain Due To Cervical Sprain Related To A Traffic Accident". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00894790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*